These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 35163633)

  • 1. Delivering Therapeutics to Glioblastoma: Overcoming Biological Constraints.
    Mathew EN; Berry BC; Yang HW; Carroll RS; Johnson MD
    Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overcoming the blood-brain tumor barrier for effective glioblastoma treatment.
    van Tellingen O; Yetkin-Arik B; de Gooijer MC; Wesseling P; Wurdinger T; de Vries HE
    Drug Resist Updat; 2015 Mar; 19():1-12. PubMed ID: 25791797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanocarriers for the treatment of glioblastoma multiforme: Current state-of-the-art.
    Karim R; Palazzo C; Evrard B; Piel G
    J Control Release; 2016 Apr; 227():23-37. PubMed ID: 26892752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategies to improve delivery of anticancer drugs across the blood-brain barrier to treat glioblastoma.
    Oberoi RK; Parrish KE; Sio TT; Mittapalli RK; Elmquist WF; Sarkaria JN
    Neuro Oncol; 2016 Jan; 18(1):27-36. PubMed ID: 26359209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comprehensive review in improving delivery of small-molecule chemotherapeutic agents overcoming the blood-brain/brain tumor barriers for glioblastoma treatment.
    Wang D; Wang C; Wang L; Chen Y
    Drug Deliv; 2019 Dec; 26(1):551-565. PubMed ID: 31928355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging of convection enhanced delivery of toxins in humans.
    Mehta AI; Choi BD; Raghavan R; Brady M; Friedman AH; Bigner DD; Pastan I; Sampson JH
    Toxins (Basel); 2011 Mar; 3(3):201-6. PubMed ID: 22069706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel delivery strategies for glioblastoma.
    Zhou J; Atsina KB; Himes BT; Strohbehn GW; Saltzman WM
    Cancer J; 2012; 18(1):89-99. PubMed ID: 22290262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nasal Drug Delivery of Anticancer Drugs for the Treatment of Glioblastoma: Preclinical and Clinical Trials.
    Bruinsmann FA; Richter Vaz G; de Cristo Soares Alves A; Aguirre T; Raffin Pohlmann A; Stanisçuaski Guterres S; Sonvico F
    Molecules; 2019 Nov; 24(23):. PubMed ID: 31779126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Convection-enhanced delivery for glioblastoma: targeted delivery of antitumor therapeutics.
    Ung TH; Malone H; Canoll P; Bruce JN
    CNS Oncol; 2015; 4(4):225-34. PubMed ID: 26103989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Convection-enhanced drug delivery for glioblastoma: a review.
    D'Amico RS; Aghi MK; Vogelbaum MA; Bruce JN
    J Neurooncol; 2021 Feb; 151(3):415-427. PubMed ID: 33611708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioscaffold-based study of glioblastoma cell behavior and drug delivery for tumor therapy.
    Tran K; Brice R; Yao L
    Neurochem Int; 2021 Jul; 147():105049. PubMed ID: 33945833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase I trial of carboplatin administered by convection-enhanced delivery to patients with recurrent/progressive glioblastoma multiforme.
    White E; Bienemann A; Taylor H; Hopkins K; Cameron A; Gill S
    Contemp Clin Trials; 2012 Mar; 33(2):320-31. PubMed ID: 22101221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overcoming Barriers in Glioblastoma-Advances in Drug Delivery Strategies.
    Ter Linden E; Abels ER; van Solinge TS; Neefjes J; Broekman MLD
    Cells; 2024 Jun; 13(12):. PubMed ID: 38920629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy Delivery Strategies to the Central Nervous System: neither Optional nor Superfluous.
    Drapeau A; Fortin D
    Curr Cancer Drug Targets; 2015; 15(9):752-68. PubMed ID: 26077730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vesicular systems employing natural substances as promising drug candidates for MMP inhibition in glioblastoma: A nanotechnological approach.
    Agarwal S; Muniyandi P; Maekawa T; Kumar DS
    Int J Pharm; 2018 Nov; 551(1-2):339-361. PubMed ID: 30236647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of nanoparticles for drug delivery in glioblastoma multiforme.
    Jain KK
    Expert Rev Neurother; 2007 Apr; 7(4):363-72. PubMed ID: 17425491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of KATP channels increases anticancer drug delivery to brain tumors and survival.
    Ningaraj NS; Sankpal UT; Khaitan D; Meister EA; Vats T
    Eur J Pharmacol; 2009 Jan; 602(2-3):188-93. PubMed ID: 19027730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Convection-enhanced delivery in glioblastoma: a review of preclinical and clinical studies.
    Jahangiri A; Chin AT; Flanigan PM; Chen R; Bankiewicz K; Aghi MK
    J Neurosurg; 2017 Jan; 126(1):191-200. PubMed ID: 27035164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel drug delivery strategies in neuro-oncology.
    Bidros DS; Vogelbaum MA
    Neurotherapeutics; 2009 Jul; 6(3):539-46. PubMed ID: 19560743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted drug delivery for treatment and imaging of glioblastoma multiforme.
    Stukel JM; Caplan MR
    Expert Opin Drug Deliv; 2009 Jul; 6(7):705-18. PubMed ID: 19538036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.